ACM Research Reports First Quarter 2026 Results
Rhea-AI Summary
ACM Research (NASDAQ: ACMR) reported Q1 2026 results: revenue $231.3M (+34.2% YoY) and shipments $240.7M (+53.6% YoY). GAAP net income was $17.3M and diluted EPS was $0.24. ACM reiterated 2026 revenue guidance of $1.08B–$1.175B (21%–30% growth).
Gross margin was 46.4% and cash, restricted cash and short-term deposits totaled approximately $1.25B at March 31, 2026.
Positive
- Revenue $231.3M, +34.2% year-over-year
- Shipments $240.7M, +53.6% year-over-year
- 2026 revenue guidance $1.08B–$1.175B (21%–30% growth)
- Gross margin 46.4%, within long-term 42%–48% target
- Cash and equivalents plus deposits ≈ $1.25B at 3/31/2026
Negative
- GAAP net income down to $17.3M from $20.4M
- Operating expenses increased 25.2%, to $71.1M
- Non-GAAP operating margin declined to 18.1% from 20.7%
Market Reaction – ACMR
Following this news, ACMR has gained 10.37%, reflecting a significant positive market reaction. Our momentum scanner has triggered 31 alerts so far, indicating elevated trading interest and price volatility. The stock is currently trading at $61.13. This price movement has added approximately $380M to the company's valuation.
Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.
Key Figures
Market Reality Check
Peers on Argus
ACMR is up 4.89% while key peers like DQ, VECO, PLAB and UCTT show declines. Only KLIC appeared in momentum scanners to the upside, suggesting a company-specific reaction rather than a sector-wide move.
Previous Earnings Reports
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Feb 26 | FY 2025 results | Positive | -16.7% | Reported FY25 revenue growth and maintained 2026 guidance despite softer margins. |
| Nov 05 | Q3 2025 earnings | Negative | -19.9% | Strong revenue but sharply lower gross margin and narrowed 2025 revenue guidance. |
| Aug 06 | Q2 2025 earnings | Positive | -15.3% | Delivered revenue growth, high gross margin and solid cash with maintained guidance. |
| Apr 29 | Prelim Q1 2025 | Positive | -11.0% | Issued Q1 2025 prelims showing revenue growth and reaffirmed full‑year outlook. |
| Feb 26 | FY 2024 results | Positive | +20.7% | Strong FY24 growth, higher operating income and shipment expansion with solid outlook. |
Earnings and related financial releases have often been followed by volatile moves, with several strong reports triggering double‑digit declines, indicating a history of sell-the-news behavior.
Over the past year, ACMR’s earnings and financial updates have featured solid revenue growth, expanding product lines, and strong cash generation. However, shares frequently moved sharply, with multiple quarters of positive or mixed earnings news followed by double‑digit declines, and only the Feb 26, 2025 and Feb 26, 2026 reports drawing strong positive alignment. Today’s Q1 2026 results and maintained 2026 outlook fit into this pattern of growth amid volatile reactions.
Historical Comparison
Historically, ACMR’s earnings headlines led to an average move of -8.45%, with several strong quarters sold off afterward, underscoring a tendency toward volatile, often contrarian post-earnings trading.
Earnings releases show continued revenue growth and product expansion from 2024 through 2025, alongside evolving guidance and margin trends that frame 2026’s growth outlook.
Market Pulse Summary
This announcement highlights strong Q1 2026 revenue of $231.3M, 34.2% growth, and maintained full‑year guidance of $1.08B–$1.175B. Shipments of $240.7M and a 46.4% gross margin underscore healthy demand, though GAAP and non‑GAAP EPS declined year over year. Compared with prior earnings, the focus remains on balancing rapid expansion, new product ramps and margin sustainability over coming quarters.
Key Terms
plasma-enhanced chemical vapor deposition medical
pecvd technical
back-end-of-line technical
rule 10b5-1 trading plan regulatory
schedule 13g/a regulatory
AI-generated analysis. Not financial advice.
FREMONT, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- ACM Research, Inc. (“ACM”) (NASDAQ: ACMR), a leading supplier of wafer processing solutions for semiconductor and advanced wafer-level packaging applications, today reported financial results for its first quarter ended March 31, 2026.
“We are off to a solid start in 2026, with revenue of
Dr. Wang continued, “We expect 2026 to be a big year for new products at ACM. Our R&D over the past 5 years, together with our internal Lingang mini-line, is paying off with industry-leading offerings across several product categories enabling our global customers to solve their evolving production challenges. We expect incremental revenue contribution from Tahoe, single-wafer SPM and vertical furnace, and increased evaluations in our panel-level horizontal plating, low-pressure panel-level flux cleaning, track, and PECVD platforms. We are also taking additional steps to expand our capabilities in global markets, including the proposed Hong Kong listing of ACM Research (Shanghai), Inc., ACM’s principal operating subsidiary (“ACM Shanghai”) and the ramp-up of our Oregon facility later this year.”
“We are maintaining our 2026 revenue outlook for
| Three Months Ended March 31, | |||||||||||||||||
| GAAP | Non-GAAP(1) | ||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||
| (dollars in thousands, except EPS) | |||||||||||||||||
| Revenue | $ | 231,263 | $ | 172,347 | $ | 231,263 | $ | 172,347 | |||||||||
| Gross margin | 46.4 | % | 47.9 | % | 46.5 | % | 48.2 | % | |||||||||
| Income from operations | $ | 36,177 | $ | 25,777 | $ | 41,798 | $ | 35,594 | |||||||||
| Net income attributable to ACM Research, Inc. | $ | 17,307 | $ | 20,380 | $ | 24,334 | $ | 31,279 | |||||||||
| Basic EPS | $ | 0.26 | $ | 0.32 | $ | 0.37 | $ | 0.49 | |||||||||
| Diluted EPS | $ | 0.24 | $ | 0.30 | $ | 0.34 | $ | 0.46 | |||||||||
| (1) | Reconciliations to U.S. generally accepted accounting principles (“GAAP”) financial measures from non-GAAP financial measures are presented below under “Reconciliation of GAAP to Non-GAAP Financial Measures.” Non-GAAP financial measures exclude stock-based compensation and, with respect to net income (loss) attributable to ACM Research, Inc. and basic and diluted earnings per share, also exclude unrealized gain (loss) on short-term investments. | ||||||||||||||||
Outlook
ACM is maintaining its revenue guidance range of
Operating Highlights and Recent Announcements
- Shipments. Total shipments in the first quarter of 2026 were
$240.7 million , versus$156.7 million in the first quarter of 2025, up53.6% . Total shipments include deliveries of repeat tools and deliveries of first tools awaiting customer acceptance for potential revenue recognition in future quarters.
- Shipped First PECVD SiCN System. ACM announced that it has shipped its first plasma-enhanced chemical vapor deposition (PECVD) silicon carbonitride (SiCN) system to a leading semiconductor manufacturer. As part of the Saturn Series within the ACM Planetary Family, the system met customer-defined process specifications in ACM’s Lingang lab and has been delivered to the customer site for final validation. Targeting advanced back-end-of-line (BEOL) requirements, the system further expands ACM’s capabilities in advanced packaging applications.
- Shipment of Advanced Packaging Equipment to Leading Global Customers. ACM completed, on schedule, shipments of its Ultra C vac-p panel-level advanced packaging vacuum cleaning system to a leading global semiconductor packaging manufacturer outside mainland China, and of its wafer-level advanced packaging systems to a leading OSAT customer in Singapore.
- Introduced ACM Planetary Family™ Product Portfolio Structure. ACM launched a unified, process‑based portfolio structure, the ACM Planetary Family, organizing its products into eight distinct families aligned with key semiconductor manufacturing steps, collectively referred to as the Eight Planets series.
- Sale of Shares of ACM Shanghai. On February 6, 2026, ACM completed the sale of approximately 4.8 million shares of ACM Shanghai, at a price of RMB160.00 per share (approximately
$23.05 per share based on the exchange rate in effect on the date of the sale), generating approximately$110 million in gross proceeds and approximately$86 million net of taxes.
- ACM Shanghai Proposed H share listing in Hong Kong. On April 17, 2026, ACM Shanghai, announced a proposed issuance of overseas listed H shares and an application for a secondary listing on the Hong Kong Stock Exchange. The initiative is intended to strengthen ACM Shanghai’s capital base, enhance competitiveness, attract and retain talent, and further expand its international market presence.
First Quarter 2026 Financial Summary
Unless otherwise noted, the following figures refer to the first quarter of 2026 and comparisons are with the first quarter of 2025.
- Revenue was
$231.3 million , up34.2% , reflecting growth from ECP (front-end and packaging), furnace and other technologies, and advanced packaging (excluding ECP), services & spares.
- Gross margin was
46.4% versus47.9% . Non-GAAP gross margin, which excludes stock-based compensation, was46.5% versus48.2% . Gross margin was above the mid-point of ACM’s long-term business model target range of42% to48% . ACM expects gross margin to vary from period to period due to a variety of factors, such as product mix, currency impacts and sales volume.
- Operating expenses were
$71.1 million , an increase of25.2% . Operating expenses as a percentage of revenue decreased to30.7% from32.9% . Non-GAAP operating expenses, which exclude the effect of stock-based compensation, were$65.8 million , up38.5% . Non-GAAP operating expenses as a percentage of revenue increased to28.4% from27.6% .
- Operating income was
$36.2 million , up40.3% compared to$25.8 million . Operating margin was15.6% compared to15.0% . Non-GAAP operating income, which excludes the effect of stock-based compensation, was$41.8 million , up17.4% compared to$35.6 million . Non-GAAP operating margin, which excludes stock-based compensation, was18.1% compared to20.7% .
- Unrealized loss on short-term investments was
$1.4 million , compared to an unrealized loss of$1.1 million . Unrealized loss reflects the change in market value of the investments by ACM Shanghai. The value is marked-to-market quarterly and is excluded in the non-GAAP financial metrics.
- Income tax expense was
$3.8 million , compared to$2.2 million .
- Net income attributable to ACM Research, Inc. was
$17.3 million , compared to$20.4 million . Non-GAAP net income attributable to ACM Research, Inc., which excludes the effect of stock-based compensation and unrealized loss on short-term investments, was$24.3 million , compared to$31.3 million .
- Net income per diluted share attributable to ACM Research, Inc. was
$0.24 , compared to$0.30 . Non-GAAP net income per diluted share, which excludes the effect of stock-based compensation and unrealized loss on short-term investments, was$0.34 , compared to$0.46 .
- Cash and cash equivalents, plus restricted cash and short-term time deposits were
$1.25 billion at March 31, 2026, compared to$1.13 billion at December 31, 2025. Net cash, which excludes short-term and long-term borrowings, was$924.2 million at March 31, 2026, versus$844.5 million at December 31, 2025.
Conference Call Details
A conference call to discuss results will be held on Thursday, May 7, 2026, at 8:00 a.m. Eastern Time (8:00 p.m. China Time). To join the conference call via telephone, participants must use the following link to complete an online registration process. Upon registering, each participant will receive email instructions to access the conference call, including dial-in information and a PIN number allowing access to the conference call. This pre-registration process is designed by the operator to reduce delays due to operator congestion when accessing the live call.
Online Registration: https://register-conf.media-server.com/register/BI67a35ea588fa4ef486e4e5460faf9982
Participants who have not pre-registered may join the webcast by accessing the link at ir.acmr.com/news-events/events.
A live and archived webcast will be available on the Investors section of the ACM website at www.acmr.com.
Use of Non-GAAP Financial Measures
ACM presents non-GAAP gross margin, operating expenses, operating income, net income attributable to ACM Research, Inc. and basic and diluted earnings per share as supplemental measures to GAAP financial measures regarding ACM’s operational performance. These supplemental measures exclude the impact of stock-based compensation, which ACM does not believe is indicative of its core operating results. In addition, non-GAAP net income attributable to ACM Research, Inc. and basic and diluted earnings per share exclude the effect of stock-based compensation and unrealized gain (loss) on short-term investments, which ACM also believes are not indicative of its core operating results. A reconciliation of each non-GAAP financial measure to the most directly comparable GAAP financial measure is provided below under “Reconciliation of GAAP to non-GAAP Financial Measures.”
ACM believes these non-GAAP financial measures are useful to investors in assessing its operating performance. ACM uses these financial measures internally to evaluate its operating performance and for planning and forecasting of future periods. Financial analysts may focus on and publish both historical results and future projections based on the non-GAAP financial measures. ACM also believes it is in the best interests of investors for ACM to provide this non-GAAP information.
While ACM believes these non-GAAP financial measures provide useful supplemental information to investors, there are limitations associated with the use of these non-GAAP financial measures. These non-GAAP financial measures may not be reported by competitors, and they may not be directly comparable to similarly titled measures of other companies due to differences in calculation methodologies. The non-GAAP financial measures are not an alternative to GAAP information and are not meant to be considered in isolation or as a substitute for comparable GAAP financial measures. They should be used only as a supplement to GAAP information and should be considered only in conjunction with ACM’s consolidated financial statements prepared in accordance with GAAP.
Forward-Looking Statements
Certain statements contained in this press release are not historical facts and may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “plans,” “expects,” “believes,” “anticipates,” “designed,” and similar words are intended to identify forward-looking statements. Forward-looking statements are based on ACM management’s current expectations and beliefs, and involve a number of risks and uncertainties that are difficult to predict and that could cause actual results to differ materially from those stated or implied by the forward-looking statements. A description of certain of these risks, uncertainties and other matters can be found in filings ACM makes with the U.S. Securities and Exchange Commission, all of which are available at www.sec.gov. Because forward-looking statements involve risks and uncertainties, actual results and events may differ materially from results and events currently expected by ACM. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. ACM undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in its expectations with regard to these forward-looking statements or the occurrence of unanticipated events.
About ACM Research, Inc.
ACM develops, manufactures and sells semiconductor process equipment spanning cleaning, electroplating, stress-free polishing, vertical furnace processes, track, PECVD, and wafer- and panel-level packaging tools, enabling advanced and semi-critical semiconductor device manufacturing. ACM is committed to delivering customized, high-performance, cost-effective process solutions that semiconductor manufacturers can use in numerous manufacturing steps to improve productivity and product yield. For more information, visit www.acmr.com.
© ACM Research, Inc. Ultra C, ACM Planetary Family and the ACM Research logo are trademarks of ACM Research, Inc. For convenience, these trademarks appear in this press release without ™ symbols, but that practice does not mean that ACM will not assert, to the fullest extent under applicable law, its rights to the trademarks.
For investor and media inquiries, please contact:
| In the United States: | The Blueshirt Group |
| Steven C. Pelayo, CFA | |
| (360) 808-5154 | |
| steven@blueshirtgroup.co | |
| In China: | The Blueshirt Group Asia |
| Gary Dvorchak, CFA | |
| +86 (138) 1079-1480 | |
| gary@blueshirtgroup.co | |
| ACM RESEARCH, INC. Condensed Consolidated Balance Sheets | ||||||||
| March 31, 2026 | December 31, 2025 | |||||||
| (Unaudited) | ||||||||
| (In thousands) | ||||||||
| Assets | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 872,269 | $ | 757,373 | ||||
| Restricted cash | 21,866 | 8,589 | ||||||
| Short-term time deposits | 358,237 | 366,591 | ||||||
| Short-term investment | 34,662 | 35,524 | ||||||
| Accounts receivable, net | 526,507 | 504,250 | ||||||
| Other receivables | 53,595 | 48,655 | ||||||
| Inventories, net | 737,995 | 702,631 | ||||||
| Advances to related parties | 870 | 2,500 | ||||||
| Prepaid expenses and other current assets | 13,352 | 10,567 | ||||||
| Total current assets | 2,619,353 | 2,436,680 | ||||||
| Property, plant and equipment, net | 324,020 | 314,830 | ||||||
| Operating lease right-of-use assets, net | 17,060 | 17,925 | ||||||
| Intangible assets, net | 2,722 | 2,847 | ||||||
| Deferred tax assets | 30,224 | 29,389 | ||||||
| Long-term investments | 68,467 | 66,035 | ||||||
| Other long-term assets | 4,052 | 4,479 | ||||||
| Total assets | $ | 3,065,898 | $ | 2,872,185 | ||||
| Liabilities and Equity | ||||||||
| Current liabilities: | ||||||||
| Short-term borrowings | $ | 93,981 | $ | 74,041 | ||||
| Current portion of long-term borrowings | 13,302 | 35,082 | ||||||
| Related parties accounts payable | 31,791 | 32,060 | ||||||
| Accounts payable | 208,867 | 215,440 | ||||||
| Advances from customers | 168,825 | 187,809 | ||||||
| Deferred revenue | 10,954 | 17,388 | ||||||
| Income taxes payable | 24,780 | 991 | ||||||
| FIN-48 payable | 28,308 | 27,719 | ||||||
| Other payables and accrued expenses | 160,075 | 150,396 | ||||||
| Current portion of operating lease liability | 4,795 | 4,786 | ||||||
| Total current liabilities | 745,678 | 745,712 | ||||||
| Long-term borrowings | 220,858 | 178,930 | ||||||
| Long-term operating lease liability | 4,125 | 5,069 | ||||||
| Other long-term liabilities | 11,765 | 11,965 | ||||||
| Total liabilities | 982,426 | 941,676 | ||||||
| Commitments and contingencies | ||||||||
| Equity: | ||||||||
| Stockholders’ equity: | ||||||||
| Class A Common stock | 6 | 6 | ||||||
| Class B Common stock | 1 | 1 | ||||||
| Additional paid-in capital | 1,194,786 | 1,115,504 | ||||||
| Retained earnings | 367,735 | 350,428 | ||||||
| Statutory surplus reserve | 34,164 | 34,164 | ||||||
| Accumulated other comprehensive loss | (15,182 | ) | (35,740 | ) | ||||
| Total ACM Research, Inc. stockholders’ equity | 1,581,510 | 1,464,363 | ||||||
| Non-controlling interests | 501,962 | 466,146 | ||||||
| Total equity | 2,083,472 | 1,930,509 | ||||||
| Total liabilities and equity | $ | 3,065,898 | $ | 2,872,185 | ||||
| ACM RESEARCH, INC. Condensed Consolidated Statements of Operations and Comprehensive Income | ||||||||
| Three Months Ended March 31, | ||||||||
| 2026 | 2025 | |||||||
| (Unaudited) | ||||||||
| (In thousands, except share and per share data) | ||||||||
| Revenue | $ | 231,263 | $ | 172,347 | ||||
| Cost of revenue | 124,025 | 89,797 | ||||||
| Gross profit | 107,238 | 82,550 | ||||||
| Operating expenses: | ||||||||
| Sales and marketing | 20,688 | 16,343 | ||||||
| Research and development | 36,549 | 27,503 | ||||||
| General and administrative | 13,824 | 12,927 | ||||||
| Total operating expenses | 71,061 | 56,773 | ||||||
| Income from operations | 36,177 | 25,777 | ||||||
| Interest income | 4,719 | 3,339 | ||||||
| Interest expense | (1,933 | ) | (1,558 | ) | ||||
| Unrealized loss on short-term investments | (1,406 | ) | (1,082 | ) | ||||
| Other expense, net | (9,300 | ) | (262 | ) | ||||
| Income from equity method investments | 1,749 | 952 | ||||||
| Income before income taxes | 30,006 | 27,166 | ||||||
| Income tax expense | (3,771 | ) | (2,153 | ) | ||||
| Net income | 26,235 | 25,013 | ||||||
| Less: Net income attributable to non-controlling interests | 8,928 | 4,633 | ||||||
| Net income attributable to ACM Research, Inc. | $ | 17,307 | $ | 20,380 | ||||
| Comprehensive income: | ||||||||
| Net income | $ | 26,235 | $ | 25,013 | ||||
| Foreign currency translation adjustment, net of tax of nil | 27,797 | 1,750 | ||||||
| Comprehensive Income | 54,032 | 26,763 | ||||||
| Less: Comprehensive income attributable to non-controlling interests | 16,167 | 4,957 | ||||||
| Comprehensive income attributable to ACM Research, Inc. | $ | 37,865 | $ | 21,806 | ||||
| Net income attributable to ACM Research, Inc. per common share: | ||||||||
| Basic | $ | 0.26 | $ | 0.32 | ||||
| Diluted | $ | 0.24 | $ | 0.30 | ||||
| Weighted average common shares outstanding used in computing per share amounts: | ||||||||
| Basic | 65,804,254 | 63,267,834 | ||||||
| Diluted | 69,769,907 | 66,952,774 | ||||||
| ACM RESEARCH, INC. Total Revenue by Product Category | ||||||
| Three Months Ended March 31, | ||||||
| 2026 | 2025 | |||||
| (Unaudited) | ||||||
| ($ in thousand) | ||||||
| Single wafer cleaning, Tahoe and semi-critical cleaning equipment | $ | 122,482 | $ | 129,569 | ||
| ECP (front-end and packaging), furnace and other technologies | 84,239 | 27,630 | ||||
| Advanced packaging (excluding ECP), services & spares | 24,542 | 15,148 | ||||
| Total Revenue By Product Category | $ | 231,263 | $ | 172,347 | ||
| ACM RESEARCH, INC. Reconciliation of GAAP to Non-GAAP Financial Measures |
As described under “Use of Non-GAAP Financial Measures” above, ACM presents non-GAAP gross margin, operating expenses, operating income, net income attributable to ACM Research, Inc., and basic and diluted earnings per share as supplemental measures to GAAP financial measures, each of which excludes stock-based compensation (“SBC”) from the equivalent GAAP financial line items. In addition, non-GAAP net income attributable to ACM Research, Inc., and basic and diluted earnings per share exclude unrealized gain (loss) on short-term investments. The following tables reconcile gross margin, operating expenses, operating income, net income attributable to ACM Research, Inc., and basic and diluted earnings per share to the related non-GAAP financial measures:
| Three Months Ended March 31, | ||||||||||||||||||||||||||||||||
| 2026 | 2025 | |||||||||||||||||||||||||||||||
| Actual (GAAP) | SBC | Other non- operating adjustments | Adjusted (Non-GAAP) | Actual (GAAP) | SBC | Other non- operating adjustments | Adjusted (Non-GAAP) | |||||||||||||||||||||||||
| (In thousands) | ||||||||||||||||||||||||||||||||
| Revenue | $ | 231,263 | $ | - | $ | - | $ | 231,263 | $ | 172,347 | $ | - | $ | - | $ | 172,347 | ||||||||||||||||
| Cost of revenue | (124,025 | ) | (348 | ) | - | (123,677 | ) | (89,797 | ) | (529 | ) | - | (89,268 | ) | ||||||||||||||||||
| Gross profit | 107,238 | (348 | ) | - | 107,586 | 82,550 | (529 | ) | - | 83,079 | ||||||||||||||||||||||
| Gross margin | 46.4 | % | 0.1 | % | - | 46.5 | % | 47.9 | % | 0.3 | % | - | 48.2 | % | ||||||||||||||||||
| Operating expenses: | ||||||||||||||||||||||||||||||||
| Sales and marketing | (20,688 | ) | (1,492 | ) | - | (19,196 | ) | (16,343 | ) | (2,157 | ) | - | (14,186 | ) | ||||||||||||||||||
| Research and development | (36,549 | ) | (1,842 | ) | - | (34,707 | ) | (27,503 | ) | (2,775 | ) | - | (24,728 | ) | ||||||||||||||||||
| General and administrative | (13,824 | ) | (1,939 | ) | - | (11,885 | ) | (12,927 | ) | (4,356 | ) | - | (8,571 | ) | ||||||||||||||||||
| Total operating expenses | (71,061 | ) | (5,273 | ) | - | (65,788 | ) | (56,773 | ) | (9,288 | ) | - | (47,485 | ) | ||||||||||||||||||
| Income (loss) from operations | 36,177 | (5,621 | ) | - | 41,798 | 25,777 | (9,817 | ) | - | 35,594 | ||||||||||||||||||||||
| Unrealized loss on short-term investments | (1,406 | ) | - | (1,406 | ) | - | (1,082 | ) | - | (1,082 | ) | - | ||||||||||||||||||||
| Net income (loss) attributable to ACM Research, Inc. | $ | 17,307 | $ | (5,621 | ) | $ | (1,406 | ) | $ | 24,334 | $ | 20,380 | $ | (9,817 | ) | $ | (1,082 | ) | $ | 31,279 | ||||||||||||
| Basic EPS | $ | 0.26 | $ | 0.37 | $ | 0.32 | $ | 0.49 | ||||||||||||||||||||||||
| Diluted EPS | $ | 0.24 | $ | 0.34 | $ | 0.30 | $ | 0.46 | ||||||||||||||||||||||||
